- Home
- ABEO vs DSP Comparison
ABEO vs DSP Comparison
Compare ABEO & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | DSP |
|---|---|---|
| Founded | 1974 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.5M | 272.1M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABEO | DSP |
|---|---|---|
| Price | $2.28 | $12.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $18.38 | ★ $19.32 |
| AVG Volume (30 Days) | ★ 1.7M | 376.6K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | 157.14 |
| EPS | N/A | ★ N/A |
| Revenue | $2,998,000.00 | ★ $344,201,000.00 |
| Revenue This Year | $731.38 | $26.65 |
| Revenue Next Year | $129.85 | $21.65 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | 19.00 |
| 52 Week Low | $2.30 | $8.72 |
| 52 Week High | $7.65 | $14.80 |
Technical Indicators
Market Signals| Indicator | ABEO | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 17.41 | 42.67 |
| Support Level | N/A | $12.11 |
| Resistance Level | $5.77 | $12.45 |
| Average True Range (ATR) | 0.30 | 0.81 |
| MACD | -0.19 | -0.14 |
| Stochastic Oscillator | 2.26 | 35.52 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.